Pluxee Shares Rally +2.63% in a Turbulent Market
Pluxee's stock is trading at €10.54 this Tuesday midday, marking a 2.63% increase from the previous day's close of €10.27. This rebound occurs in a context of a moderate recovery of the CAC 40, which is up 0.73% during the session. However, the momentum remains fragile for the employee benefits specialist, whose share price has dropped nearly 48.5% over the year.
Market Context and Recent Performance
This Tuesday, Pluxee is experiencing a bullish surge after several weeks of decline. Over three months, the stock still shows a decrease of 20.69%, while the performance over seven days remains almost stable (+0.29%). This rebound is part of a generally positive session for the Parisian stock market, with the SBF 120 up 0.77% during the session. The market environment remains tense, as evidenced by the VIX volatility index, which was at 31.05 points at last Friday's close, indicating high stress levels. Geopolitical tensions in the Middle East, with oil prices soaring beyond $115 per barrel on Monday, affect overall visibility, although their direct impact on Pluxee's business—focused on prepaid services and employee benefits—is not immediate. In terms of sector comparison, Capgemini is up 3.55% during the session, while Sartorius Stedim Biotech is down 1.71%.
Technical Analysis and Financial Outlook
Technically, Pluxee's stock price is below its 50-day moving average (€10.97) and remains far from its 200-day moving average (€14.60), indicating a persistent bearish trend that has not yet reversed. The RSI, a momentum indicator measuring the speed of price changes, stands at 44, which is a neutral level but still oriented below the threshold of 50, suggesting that selling pressure has not completely disappeared. The nearest technical support is at €9.97, a zone tested during recent lows. Regarding the financial calendar, investors are awaiting the publication of the first half of 2026 results, scheduled for April 16. This milestone will be an important point to assess the operational trajectory of the group, which emerged from the split of Sodexo, in a year marked by persistent pressure on stock valuation.
